2.
Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0
by Boers, Maarten
Journal of clinical epidemiology, 2014, Vol.67 (7), p.745-753
3.
EULAR recommendations for patient education for people with inflammatory arthritis
by Zangi, Heidi A
Annals of the rheumatic diseases, 2015, Vol.74 (6), p.954-962
4.
Moving towards online rheumatology education in the era of COVID-19
by Ahmed, Sakir
Clinical rheumatology, 2020, Vol.39 (11), p.3215-3222
5.
International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies
by Agmon-Levin, Nancy
Annals of the Rheumatic Diseases, 2014, Vol.73 (1), p.17-23
6.
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
by Aletaha, D
Annals of the rheumatic diseases, 2010, Vol.69 (9), p.1580-1588
7.
Impact of COVID-19 on rheumatology practice in the UK—a pan-regional rheumatology survey
by Nune, Arvind
Clinical rheumatology, 2021, Vol.40 (6), p.2499-2504
8.
Challenges, collaboration, and innovation in rheumatology education during the COVID-19 pandemic: leveraging new ways to teach
by Dua, Anisha B
Clinical rheumatology, 2020, Vol.39 (12), p.3535-3541
9.
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
by van den Hoogen, Frank
Annals of the rheumatic diseases, 2013, Vol.72 (11), p.1747-1755
10.
Challenges in delivering rheumatology care during COVID-19 pandemic
by Nune, A
Clinical rheumatology, 2020, Vol.39 (9), p.2817-2821
12.
Capacity building for the provision of rheumatological services in sub-Saharan Africa
by Eastin, Jennifer
Clinical rheumatology, 2020, Vol.40 (9), p.3439-3443
13.
The global challenges and opportunities in the practice of rheumatology: White paper by the World Forum on Rheumatic and Musculoskeletal Diseases
by Al Maini, Mustafa
Clinical rheumatology, 2014, Vol.34 (5), p.819-829
14.
Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis
by Qin, Baodong
Annals of the rheumatic diseases, 2015, Vol.74 (11), p.1983-1989
15.
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis
by Fernandes, Linda
Annals of the rheumatic diseases, 2013, Vol.72 (7), p.1125-1135
16.
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
by van den Hoogen, Frank
Annals of the rheumatic diseases, 2013, Vol.72 (11), p.1747
17.
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force
by Smolen, Josef S
Annals of the rheumatic diseases, 2014, Vol.73 (1), p.6-16
18.
Are antiphospholipid antibodies just a common epiphenomenon or are they causative of immune-mediated coagulopathy in COVID-19?
by Castillo-Martínez, Diana
Clinical rheumatology, 2021, Vol.40 (7), p.3015-3019
19.
Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study
by Elhai, Muriel
Annals of the rheumatic diseases, 2013, Vol.72 (7), p.1217-1220
20.
Osteoarthritis research priorities: a report from a EULAR ad hoc expert committee
by Conaghan, Philip G
Annals of the rheumatic diseases, 2014, Vol.73 (8), p.1442-1445
